Industry reports
Editor highlights

Publication dates

Carcinoma Research Reports, April 2014

You might be interested in: cancer, therapeutics, microbiology, more »


 

1-10 of 62 reports for Carcinoma
Colon Carcinoma - Pipeline Review, H1 2014

Colon Carcinoma - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • March 2014
  • by Global Markets Direct

... A snapshot of the global therapeutic landscape of colon carcinoma- the report reviews key pipeline products under drug profile section which includes, product description, moa and r&d brief, licensing ...

Gastroesophageal (GE) Junction Carcinomas Global Clinical Trials Review, H1, 2014

Gastroesophageal (GE) Junction Carcinomas Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

... Provides elemental information and data relating to the clinical trials on gastroesophageal (ge) junction carcinomas. It includes an overview of the trial numbers and their recruitment status as per the site ...

Head And Neck Carcinoma Global Clinical Trials Review, H1, 2014

Head And Neck Carcinoma Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

... Trials on head and neck carcinoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...

NSCLC Therapeutics in Asia-Pacific Markets to 2019 - Personalized Therapies Focus on Untapped Segment of Squamous Cell Carcinoma to Expand Treatment Pool

NSCLC Therapeutics in Asia-Pacific Markets to 2019 - Personalized Therapies Focus on Untapped Segment of Squamous Cell Carcinoma to Expand Treatment Pool

  • $ 3 500
  • Industry report
  • March 2014
  • by GBI Research

... To 2019 - personalized therapies focus on untapped segment of squamous cell carcinoma to expand treatment poolsummarygbi research, the leading business intelligence provider, has ...

Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2014

Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • February 2014
  • by Global Data

... Trials on hepatocellular carcinoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary ...

Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2014

Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

... Pipeline projects- coverage of the metastatic renal cell carcinoma pipeline on the basis of target, moa, route of administration and molecule type- latest news and deals relating related to pipeline ...

Pathology in United States: Neuro Endocrine (Carcinoid) Carcinoma – Pipeline Review, H1 2012

Pathology in United States: Neuro Endocrine (Carcinoid) Carcinoma – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

... Endocrine (carcinoid) carcinoma- the report reviews key pipeline products under drug profile section which includes, product description, moa and r&d brief, licensing and collaboration details & other ...

Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H1, 2014

Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • February 2014
  • by Global Data

... Briefing pertaining to the number of trials for the key drugs for treating basal cell carcinoma (basal cell epithelioma) . This report is built using data and information sourced from proprietary databases ...

Adrenocortical Carcinoma (Adrenal Cortex Cancer) Global Clinical Trials Review, H1, 2014

Adrenocortical Carcinoma (Adrenal Cortex Cancer) Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • February 2014
  • by Global Data

... Provides briefing pertaining to the number of trials for the key drugs for treating adrenocortical carcinoma (adrenal cortex cancer) . This report is built using data and information sourced from proprietary ...

Sunshine Biopharma, Inc. (Symbol:SBFM) SWOT Analysis, Strategy, Revenues and Profits

Sunshine Biopharma, Inc. (Symbol:SBFM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • February 2014
  • by Global Data

... Targeted for various forms of cancer such as breast cancer (mcf-7/mdr), small-cell lung cancer (h69ar), uterine carcinoma (mes-sa/dx5) and pancreatic cancer (panc-1). The company also offers difluoro ...


» Read our Company Profiles

1 Companies for Carcinoma

Novartis Inc.

Switzerland

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.